[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07641413":3,"trial-entities:NCT07641413":122,"trial-summary:NCT07641413":126},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":23,"study_type":30,"primary_purpose":31,"phases":32,"enrollment_info":33,"interventions":36,"primary_outcomes":40,"secondary_outcomes":49,"sex":60,"minimum_age":61,"maximum_age":62,"healthy_volunteers":63,"eligibility_criteria":64,"std_ages":88,"locations":91,"central_contacts":108,"overall_officials":110,"references":113,"see_also_links":121},"NCT07641413","UCSF IRB#24-41051","Lung and Heart Function Across Decades of Life in Health","Lung and Heart Function Across Decades of Life in Healthy Population","RECRUITING","2030-12-31","2026-06","2026-06-11","2024-08-01","University of California, San Francisco","OTHER",false,"The main objective of this study is to develop baseline \"normal\" reference values of both lung and heart function for healthy adults within the age range relevant to the United States Veteran population who served in the Southwest Asia theater of military operations.\n\nThis study will involve performing key components of the Department of Veterans Affairs the Airborne Hazards and Open Burn Pit Center of Excellence (AHOBPCE) and a VA network of Post-Deployment Cardiopulmonary Evaluation Network (PDCEN) Core Clinical Evaluation in asymptomatic unexposed healthy controls without known lung or heart disease to serve as a \"normal\" control comparator group for veterans evaluated by PDCEN.","This is an observational study to recruit and thoroughly characterize 200 age- and gender-matched healthy controls without a history of exposure to airborne hazards. The childhood health and disease profiles of participants will also be evaluated to provide assessment of their physical fitness as adolescents. The participants will undergo detailed clinical, physiological, and radiological evaluations that will match the PDCEN Core Clinical Evaluation, which includes administration of health, environmental and occupational exposures, respiratory, and physical fitness questionnaires, pulmonary function testing (PFT), forced oscillometry (FOT), cardiopulmonary exercise testing (CPET) with maximum effort, dynamic hyperinflation, and exercise-induced bronchospasm protocols, methacholine challenge testing, transthoracic echocardiography, and computer tomography (CT) of chest, as well as pulmonary and systemic biomarker analysis including fractional exhalation of nitric oxide (FeNO) and peripheral blood sampling for blood count and metabolic panel including liver and kidney function.",[19,20,21,22],"Pollution Related Respiratory Disorder","Pollution; Exposure","Dyspnea","Cardiopulmonary",[24,25,26,27,28,29],"Cardiopulmonary function","Pulmonary function testing","Forced oscillometry testing","Echocardiography","Cardiopulmonary exercise testing","Computed tomography imaging","OBSERVATIONAL",null,[],{"count":34,"type":35},200,"ESTIMATED",[37],{"type":14,"name":38,"description":39},"Healthy control","Observational study with no intervention",[41,45,47],{"measure":42,"description":43,"timeFrame":44},"Normal reference values for heart and lung function within the age range relevant to the United States Veteran population.","Pulmonary Function Testing: The purpose of this test is to determine the participant's lungs' capacity.","2 years",{"measure":42,"description":46,"timeFrame":44},"Cardiopulmonary Exercise Testing: The purpose of this test is to determine the participant's lung and heart capacity during maximum exercise.",{"measure":42,"description":48,"timeFrame":44},"Echocardiogram: The purpose of this test is to determine how well the subject's heart is functioning and identify causes of cardiac-related symptoms.",[50,52,54,56,58],{"measure":42,"description":51,"timeFrame":44},"FeNO: The purpose of this test is to measure a marker of inflammation in the lungs.",{"measure":42,"description":53,"timeFrame":44},"Forced Oscillation Technique: The purpose of this test is to determine the resistance of the airways in the subject's lungs.",{"measure":42,"description":55,"timeFrame":44},"Methacholine Challenge Test: The purpose of this test is to determine how irritable the participant's airways are by administering gradually increasing doses of methacholine.",{"measure":42,"description":57,"timeFrame":44},"Chest CT: The purpose of this test is to examine for abnormalities and to help diagnose the cause of signs or symptoms of chest disease.",{"measure":42,"description":59,"timeFrame":44},"Peripheral Blood Draw: The purpose of this blood draw is to determine metabolic and blood inflammatory markers.","ALL","24 Years","68 Years",true,{"inclusion":65,"exclusion":69,"raw_text":87},[66,67,68],"Age 24-68","No respiratory complaints (defined as modified Medical Research Council score = 0)","No use of respiratory medications",[70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86],"Non-English speaking","Pregnancy","BMI\\>35 Kg\u002Fm2","Tobacco smoking within prior year","Lifetime tobacco smoking of \\>5 pack-years","Current inhaled cannabis use (any modality) \\>2x weekly","Prior inhaled cannabis uses exceeding 2x weekly within the prior year","Illicit drug use (other than cannabis)","No prior or current major organ disease, including but not limited to:","Neuromuscular weakness","History of malignancy (other than non-melanoma skin cancer)-- HIV\u002FAIDS","Autoimmune disease","Solid-organ or hematopoietic stem cell transplant","Cardiovascular disease (other than mild HTN; \\\u003C 140\u002F90; controlled on 2 or less medications)","Poorly-controlled HTN (SBP\\>140 or DBP\\>90 or use of more than 2 anti-hypertensive medications)","Any history of congestive heart failure (CHF, either HFpEF or HFrEF)","Any history of arrythmia (including atrial fibrillation)","Inclusion Criteria:\n\n* Age 24-68\n* No respiratory complaints (defined as modified Medical Research Council score = 0)\n* No use of respiratory medications\n\nExclusion Criteria:\n\n* Non-English speaking\n* Pregnancy\n* BMI\\>35 Kg\u002Fm2\n* Tobacco smoking within prior year\n* Lifetime tobacco smoking of \\>5 pack-years\n* Current inhaled cannabis use (any modality) \\>2x weekly\n* Prior inhaled cannabis uses exceeding 2x weekly within the prior year\n* Illicit drug use (other than cannabis)\n* No prior or current major organ disease, including but not limited to:\n\n  * Neuromuscular weakness\n  * History of malignancy (other than non-melanoma skin cancer)-- HIV\u002FAIDS\n  * Autoimmune disease\n  * Solid-organ or hematopoietic stem cell transplant\n  * Cardiovascular disease (other than mild HTN; \\\u003C 140\u002F90; controlled on 2 or less medications)\n\n    * Poorly-controlled HTN (SBP\\>140 or DBP\\>90 or use of more than 2 anti-hypertensive medications)\n    * Any history of congestive heart failure (CHF, either HFpEF or HFrEF)\n    * Any history of arrythmia (including atrial fibrillation)",[89,90],"ADULT","OLDER_ADULT",[92],{"facility":93,"status":8,"city":94,"state":95,"zip":96,"country":97,"contacts":98,"geoPoint":105},"University of California San Francisco","San Francisco","California","94143","United States",[99],{"name":100,"role":101,"phone":102,"phoneExt":103,"email":104},"Mehrdad Arjomandi, MD","CONTACT","415-221-4810","24393","mehrdad.arjomandi@ucsf.edu",{"lat":106,"lon":107},37.77493,-122.41942,[109],{"name":100,"role":101,"phone":102,"phoneExt":103,"email":104},[111],{"name":100,"affiliation":13,"role":112},"PRINCIPAL_INVESTIGATOR",[114,118],{"pmid":115,"type":116,"citation":117},"38245665","BACKGROUND","Zeng S, Nishihama M, Weldemichael L, Lozier H, Gold WM, Arjomandi M. Effect of twice daily inhaled albuterol on cardiopulmonary exercise outcomes, dynamic hyperinflation, and symptoms in secondhand tobacco-exposed persons with preserved spirometry and air trapping: a randomized controlled trial. BMC Pulm Med. 2024 Jan 20;24(1):44. doi: 10.1186\u002Fs12890-023-02808-7.",{"pmid":119,"type":116,"citation":120},"35551073","Zeng S, Dunn M, Gold WM, Kizer JR, Arjomandi M. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume. BMJ Open Respir Res. 2022 May;9(1):e001217. doi: 10.1136\u002Fbmjresp-2022-001217.",[],{"nct_id":4,"conditions":123,"biomarkers":125},[124],"Healthy Volunteers",[],{"nct_id":4,"found":15,"summary":31,"prompt_version":31}]